References
- 1. Chibaudel B, Tournigand C, André T, de Gramont A. Therapeutic strategy in unresectable metastatic colorectal cancer // Therapeutic Advances in Medical Oncology, 2011; 4 issue: 2, page(s): 75–89.10.1177/1758834011431592329608122423266
- 2. Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 2013; 100:75–82.10.1002/bjs.894523132548
- 3. Hogan NM, Winter DC A nodal positivity constant: new perspectives in lymph node evaluation and colorectal cancer. World J Surg 2013; 37:878–82.10.1007/s00268-012-1891-723242459
- 4. Karyn B. Stitzenberg, MD, MPH, FACS Associate Professor of Surgery said on Society of Surgical Oncology (SSO) 66th Annual Cancer Symposium. (Abstract 75. Presented March 8, 2013.)
- 5. Kopsavilkums par onkoloǵiskajiem pacientiem Latvijā. 2001.–2017. Slimību profilakses un kontroles centra mājaslapa (spkc.gov.lv).
- 6. Valderrama-Treviño AI, Barrera-Mera B, Ceballos-Villalva JC, Montalvo Javécorresponding EE. Hepatic Metastasis from Colorectal Cancer // Euroasian Journal of Hepato-Gastroenterology, 2017; 7(2): 166–175.